Vitrolife AB (publ)

OM:VITR Stock Report

Market Cap: SEK 19.9b

Vitrolife Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VITR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders46,4000.0343%
VC/PE Firms21,510,25715.9%
General Public26,485,43119.6%
Institutions87,380,53464.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.7%
William Demant Invest A/S
38,829,825SEK 5.7b0%9.59%
15.9%
Bure Equity AB (publ)
21,510,257SEK 3.2b0%19.18%
5.28%
AMF Fonder AB
7,144,219SEK 1.1b0%0.25%
3.41%
Fourth Swedish National Pension Fund (AP4)
4,620,412SEK 680.6m0%0.35%
3.35%
Swedbank Robur Fonder AB
4,542,402SEK 669.1m0%0.04%
2.14%
Capital Research and Management Company
2,891,854SEK 426.0m0%no data
2.11%
Cliens Kapitalförvaltning AB
2,850,825SEK 419.9m0%1.03%
2.07%
The Vanguard Group, Inc.
2,809,225SEK 413.8m0%no data
2.06%
SEB Investment Management AB
2,784,396SEK 410.1m0%0.07%
2.01%
Handelsbanken Asset Management
2,728,673SEK 401.9m0%0.06%
1.98%
GLG Partners, Inc.
2,677,259SEK 394.4m0%0.73%
1.11%
Norges Bank Investment Management
1,500,591SEK 221.0m-1.62%no data
1.04%
Tredje AP-fonden
1,410,473SEK 207.8m0%0.08%
0.99%
C WorldWide Asset Management Fondsmaeglerselskab A/S
1,334,507SEK 196.6m0%0.17%
0.84%
Premier Fund Managers Ltd.
1,134,389SEK 167.1m0%0.22%
0.81%
BlackRock, Inc.
1,096,916SEK 161.6m3.51%no data
0.74%
Forsta AP-fonden
997,392SEK 146.9m0%0.05%
0.67%
Dimensional Fund Advisors LP
905,655SEK 133.4m7.96%no data
0.63%
Comgest S.A.
851,292SEK 125.4m0%0.06%
0.5%
Allianz Asset Management GmbH
671,894SEK 99.0m0%0.01%
0.45%
Danske Bank A/S
609,565SEK 89.8m0%0.07%
0.44%
Storebrand Fonder AB,
595,942SEK 87.8m0%0.03%
0.41%
Skandia Fonder AB
557,131SEK 82.1m0%0.06%
0.37%
E. Öhman J:or Wealth Management
503,003SEK 74.1m0%0.04%
0.28%
Morgan Stanley Investment Management Inc.
374,958SEK 55.2m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 04:02
End of Day Share Price 2025/10/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vitrolife AB (publ) is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Kallum TitchmarshBofA Global Research